Benzinga | Nov 10, 2021 07:15AM EST

Barclays Maintains Overweight on Cardinal Health, Lowers Price Target to $65

Barclays analyst Steve Valiquette maintains Cardinal Health (NYSE:CAH) with a Overweight and lowers the price target from $68 to $65.